1-(carboxymethylthio)tetradecane has been researched along with Coronary Restenosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berge, RK; Bohov, P; Kuiper, KK; Larsen, TH; Nordrehaug, JE; Pettersen, RJ; Rotevatn, S; Salem, M | 1 |
| Berge, RK; Gudbrandsen, OA; Kuiper, KK; Muna, ZA; Nordrehaug, JE; Salem, M | 1 |
| Berge, K; Berge, RK; Grav, H; Gudbrandsen, OA; Skorve, J; Tronstad, KJ | 1 |
1 review(s) available for 1-(carboxymethylthio)tetradecane and Coronary Restenosis
| Article | Year |
|---|---|
Metabolic effects of thia fatty acids.
Topics: Animals; Cell Differentiation; Cholesterol; Coronary Restenosis; Fatty Acids; Glucose; Homeostasis; Humans; Liver; Mice; Mitochondria; Propionates; Rats; Receptors, Cytoplasmic and Nuclear; Sulfides; Sulfur; Transcription Factors | 2002 |
2 other study(ies) available for 1-(carboxymethylthio)tetradecane and Coronary Restenosis
| Article | Year |
|---|---|
Effects of local delivery of tetradecylthioacetic acid within the injured coronary vessel wall.
Topics: Angioplasty, Balloon, Coronary; Animals; Anti-Inflammatory Agents; Cardiac Catheters; Cell Proliferation; Collagen; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Delivery Systems; Female; Inflammation Mediators; Interleukin-2; Lipid Metabolism; Male; Sulfides; Sus scrofa; Time Factors; Vascular System Injuries | 2012 |
Dose-dependent coronary artery intimal thickening after local delivery of the anti-oxidant tetradecylthioacetic acid from stents.
Topics: Animals; Antioxidants; Arachidonic Acid; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Equipment Design; Fatty Acids; Inflammation; Random Allocation; Stents; Sulfides; Swine; Time Factors; Tunica Intima | 2007 |